Sixth report of adverse events with biological treatments in Argentina. BIOBADASAR registry report

  • G. Gómez Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • G. Pons-Estel Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • G. Citera Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • E. Soriano Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • V. Saurit Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • F. Benavidez Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • E. Velozo Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • D. Dubinsky Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • I. Exeni Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • C. Gobi Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • G. Gómez Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • M. Díaz Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • A. Granel Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • A. Smichowsky Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • G. Garate Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • A. Quinteros Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • E. Cavillon Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • I. Petkovic Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • M.S. Larroude Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • M. de la Sota Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • A.M. Cappuccio Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • G. Berbotto Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • A. Alvarez Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • S. Papasidero Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • A. Lazaro Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • M. Garcia Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • M. Sacnun Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • S. Soares de Souza Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • A. Bertoli Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • V. Bejarano Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • O. Rillo Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • E. Kerzberg Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • R. Quintana Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • S. Agüero Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • L. Somma Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • V. Cruzat Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • C. Battaglitti Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • A. Perez Dávila Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • M. Gallardo Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • D. Pereira Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • M. Verando Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • S. Paira Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • L. Martinez Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • N. Aste Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • C. Pisoni Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • E. Catay Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • C. Graf Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • G. Casado Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
  • M. de la Vega Argentine Society of Rheumatology, Autonomous City of Buenos Aires, Argentina
DOI: https://doi.org/10.47196/rar.v30i1.461
Keywords: register, adverse events, biologics

Abstract

Objective: update the results of the BIOBADASAR registry on safety, duration and causes of treatment interruption after 8 years of follow-up. Methods: BIOBADASAR is a safety record of biological therapies established by the Argentine Society of Rheumatology. The description of BIOBADASAR 3.0 is presented, a cohort of 53 centers in Argentina followed prospectively from August 2010 to January 2018.

References

I. M de la Vega, et al. Primer reporte de eventos adversos de tratamientos biológicos en Argentina. Informe de Registro BIOBADASAR. Rev Arg Reumatol. 2011; 22(4):40-54.

II. Braun J, Kalden JR. Biologics in the treatment of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2009; 27(4 supple 55):S164-7.

III. MA Descalzo, L Carmona y grupo de estudio BIOBADASER. Biobadaser 2.0: análisis y tendencias en 2009. Reumatol Clin. 2010; 6(5):240-243.

IV. W orldHealthOrganization. Guidelines On Evaluation Of Similar Biotherapeutic Products (SBPs). 2009.

http://www.who.int/biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR _WEB_22APRIL2010.pdf

V. European Medicines Agency. Guide line on similar biological medicinal products containing monoclonal antibodies – non-clinical and clinical issues.

http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500128686.pdf

VI. C. Rodríguez Lozano. Seguridad de las terapias biológicas: nuevos datos de BIOBADASER. Reumatol Clin. 2011; 6(S3):S1– S6.

VII. European Medicines Agency. Questions and answers on biosimilar medicines (similar biological medicinal products). http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/12/WC50 0020062.pdf

VIII. Informe anual Biobadaser 2017. Registro español de acontecimientos adversos de terapia biológica en enfermedades reumáticas. Fase III. Sociedad Española de Reumatologia. 2018.

IX. M de la Vega, et al. Características de los tratamientos biológicos en enfermedades reumáticas en Argentina. Quinto informe del registro BIOBADASAR. Rev Arg Reumatol. 2016; 27(1):14-24.

X. M de la Vega, et al. Cuarto reporte de efectos adversos con tratamientos biológicos en Argentina. Informe de registro Biobadasar 2.0. Sociedad Argentina de Reumatologia. 2014.

XI. T itton DC, Silveira IG, Louzada-Junior P, et al. Brazilian Biologic Register: Biobadabrasil implementation process and preliminary results. Rev Bras Reumatol 2011; 51(2):145-160.

Published
2019-03-01
How to Cite
1.
Gómez G, Pons-Estel G, Citera G, Soriano E, Saurit V, Benavidez F, Velozo E, Dubinsky D, Exeni I, Gobi C, Gómez G, Díaz M, Granel A, Smichowsky A, Garate G, Quinteros A, Cavillon E, Petkovic I, Larroude M, de la Sota M, Cappuccio A, Berbotto G, Alvarez A, Papasidero S, Lazaro A, Garcia M, Sacnun M, Soares de Souza S, Bertoli A, Bejarano V, Rillo O, Kerzberg E, Quintana R, Agüero S, Somma L, Cruzat V, Battaglitti C, Perez Dávila A, Gallardo M, Pereira D, Verando M, Paira S, Martinez L, Aste N, Pisoni C, Catay E, Graf C, Casado G, de la Vega M. Sixth report of adverse events with biological treatments in Argentina. BIOBADASAR registry report. Rev. Argent. Reumatol. [Internet]. 2019Mar.1 [cited 2025May13];30(1):4 -9. Available from: https://ojs.reumatologia.org.ar/index.php/revistaSAR/article/view/461
Issue
Vol. 30 No. 1 (2019): January-March 2019
Section
Original Article

Copyright (c) 2019 Argentine Journal of Rheumatology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.